Ionis Pharmaceuticals, Inc. (IONS) vs Iovance Biotherapeutics, Inc. (IOVA)
- Ionis Pharmaceuticals, Inc. IONS 42.94 −2.67%
- Iovance Biotherapeutics, Inc. IOVA 13.58 −7.74%
Ionis Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc. are both Biotechnology companies. Ionis Pharmaceuticals, Inc. and Iovance Biotherapeutics, Inc. are of similar size ($7.3B and $6.7B). Iovance Biotherapeutics, Inc. grew revenue faster over the last twelve months: 34.6% against −7.41%. Ionis Pharmaceuticals, Inc. has the higher net margin (−64.7% vs −89.1%) and the higher return on invested capital (0.00% vs −43.0%). Across the 17 metrics below, Ionis Pharmaceuticals, Inc. leads on 10 and Iovance Biotherapeutics, Inc. on 7.
Valuation
Profitability
| Metric | IONS | IOVA | Biotechnology median |
|---|---|---|---|
| Gross margin | 98.17% | 48.40% | 65.16% |
| Operating margin | (68.00%) | (92.72%) | 0.00% |
| Net margin | (64.66%) | (89.09%) | 0.00% |
| Free cash flow margin | (64.93%) | (91.21%) | 0.00% |
| Return on equity | (105.50%) | (40.36%) | (56.36%) |
| Return on assets | (18.90%) | (31.76%) | (48.04%) |
| Return on invested capital | 0.00% | (42.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack